Keryx Biopharmaceuticals to Webcast its Presentations at Investor Healthcare Conferences in September 2017
September 05 2017 - 8:01AM
Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical
company focused on bringing innovative medicines to people with
kidney disease, today announced it will webcast corporate
presentations at the following investor conferences in September:
- A fireside chat at Morgan Stanley’s Global Healthcare
Conference in New York City on Tuesday, September 12, 2017 at 12:55
p.m. EDT.
- Cantor Fitzgerald’s Global Healthcare Conference in New York
City on Monday, September 25, 2017 at 4:45 p.m. EDT.
- Ladenburg Thalmann’s 2017 Healthcare Conference in New York
City on Tuesday, September 26 at 11:30 a.m. EDT.
Live audio webcasts of the presentations will be
accessible from Keryx Biopharmaceuticals’ website at
http://investors.keryx.com within the Investor Relations section
under “webcasts and presentations.” An archived version of the
webcast will be available for at least 15 days following the
conclusion of the live presentations.
About Keryx Biopharmaceuticals,
Inc. Keryx Biopharmaceuticals, Inc., with headquarters in
Boston, Massachusetts, is a commercial stage company focused on
bringing innovative medicines to people with kidney disease. Keryx
developed and commercializes Auryxia® (ferric citrate) in the U.S.
Ferric citrate is marketed as Riona® by Keryx’s Japanese
partner, Japan Tobacco Inc. and Torii Pharmaceutical Co. Ltd. In
September 2015, the European Commission granted European market
authorization for Fexeric® (ferric citrate coordination
complex). Keryx has programs underway to leverage its
development and commercial infrastructure, including potentially
expanding the indication of Auryxia and in-licensing medicines
for renal disease. For more information about Keryx, please
visit www.keryx.com.
KERYX BIOPHARMACEUTICALS CONTACT:
Lora Pike
Senior Director, Investor Relations & Corporate Communications
T: 617-466-3511
lora.pike@keryx.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Oct 2023 to Oct 2024